This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dornan, D.
Right arrow Articles by Ball, K. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dornan, D.
Right arrow Articles by Ball, K. L.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, November 2004, p. 10083-10098, Vol. 24, No. 22
0270-7306/04/$08.00+0     DOI: 10.1128/MCB.24.22.10083-10098.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Interferon Regulatory Factor 1 Binding to p300 Stimulates DNA-Dependent Acetylation of p53

David Dornan,1,{dagger} Mirjam Eckert,2 Maura Wallace,2 Harumi Shimizu,1,{dagger} Eleanor Ramsay,2 Ted R. Hupp,1 and Kathryn L. Ball2*

CRUK p53 Signal Transduction Group,1 CRUK Interferon and Cell Signalling Group, Cell Signalling Unit, Cancer Research Centre, University of Edinburgh, Western General Hospital, Edinburgh, United Kingdom2

Received 19 November 2003/ Returned for modification 2 March 2004/ Accepted 13 August 2004

Interferon regulatory factor 1 (IRF-1) and p53 control distinct sets of downstream genes; however, these two antioncogenic transcription factors converge to regulate p21 gene expression and to inhibit tumor formation. Here we investigate the mechanism by which IRF-1 and p53 synergize at the p21 promoter and show that stimulation of p21 transcription by IRF-1 does not require its DNA-binding activity but relies on the ability of IRF-1 to bind the coactivator p300 and to stimulate p53-dependent transcription by an allosteric mechanism. Deletion of the p300-binding sites in IRF-1 eliminates the ability of IRF-1 to stimulate p53 acetylation and associated p53 activity. Complementing this, small peptides derived from the IRF-1-p300 interface can bind to p300, stabilize the binding of p300 to DNA-bound p53, stimulate p53 acetylation in trans, and up-regulate p53-dependent activity from the p21 promoter. The nonacetylatable p53 mutant (p53-6KR) cannot be stimulated by IRF-1, further suggesting that p53 acetylation is the mechanism whereby IRF-1 modifies p53 activity. These data expand the core p300-p53 protein LXXLL and PXXP interface by including an IRF-1-p300 interface as an allosteric modifier of DNA-dependent acetylation of p53 at the p21 promoter.

* Corresponding author. Mailing address: CRUK Interferon and Cell Signalling Group, Cell Signalling Unit, Cancer Research Centre, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, United Kingdom. Phone: 44 (0) 131-777-3500. Fax: 44 (0) 131-777-3520. E-mail: Kathryn.Ball{at}ed.ac.uk.

{dagger} Present address: Genentech Inc., South San Francisco, CA 94080.

Molecular and Cellular Biology, November 2004, p. 10083-10098, Vol. 24, No. 22
0022-538X/04/$08.00+0     DOI: 10.1128/MCB.24.22.10083-10098.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Narayan, V., Eckert, M., Zylicz, A., Zylicz, M., Ball, K. L. (2009). Cooperative Regulation of the Interferon Regulatory Factor-1 Tumor Suppressor Protein by Core Components of the Molecular Chaperone Machinery. J. Biol. Chem. 284: 25889-25899 [Abstract] [Full Text]  
  • Koeppel, M., van Heeringen, S. J., Smeenk, L., Navis, A. C., Janssen-Megens, E. M., Lohrum, M. (2009). The novel p53 target gene IRF2BP2 participates in cell survival during the p53 stress response. Nucleic Acids Res 37: 322-335 [Abstract] [Full Text]  
  • Moschonas, A., Kouraki, M., Knox, P. G., Thymiakou, E., Kardassis, D., Eliopoulos, A. G. (2008). CD40 Induces Antigen Transporter and Immunoproteasome Gene Expression in Carcinomas via the Coordinated Action of NF-{kappa}B and of NF-{kappa}B-Mediated De Novo Synthesis of IRF-1. Mol. Cell. Biol. 28: 6208-6222 [Abstract] [Full Text]  
  • Craig, A. L., Chrystal, J. A., Fraser, J. A., Sphyris, N., Lin, Y., Harrison, B. J., Scott, M. T., Dornreiter, I., Hupp, T. R. (2007). The MDM2 Ubiquitination Signal in the DNA-Binding Domain of p53 Forms a Docking Site for Calcium Calmodulin Kinase Superfamily Members. Mol. Cell. Biol. 27: 3542-3555 [Abstract] [Full Text]  
  • Eckert, M., Meek, S. E. M., Ball, K. L. (2006). A Novel Repressor Domain Is Required for Maximal Growth Inhibition by the IRF-1 Tumor Suppressor. J. Biol. Chem. 281: 23092-23102 [Abstract] [Full Text]  
  • Zhao, Y., Lu, S., Wu, L., Chai, G., Wang, H., Chen, Y., Sun, J., Yu, Y., Zhou, W., Zheng, Q., Wu, M., Otterson, G. A., Zhu, W.-G. (2006). Acetylation of p53 at Lysine 373/382 by the Histone Deacetylase Inhibitor Depsipeptide Induces Expression of p21Waf1/Cip1.. Mol. Cell. Biol. 26: 2782-2790 [Abstract] [Full Text]  
  • Gupta, P., Huq, M. D. M., Khan, S. A., Tsai, N.-P., Wei, L.-N. (2005). Regulation of Co-repressive Activity of and HDAC Recruitment to RIP140 by Site-specific Phosphorylation. Mol. Cell. Proteomics 4: 1776-1784 [Abstract] [Full Text]  
  • Huq, M. D. M., Wei, L.-N. (2005). Post-translational Modification of Nuclear Co-repressor Receptor-interacting Protein 140 by Acetylation. Mol. Cell. Proteomics 4: 975-983 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»